Principles of radiological protection and application of ALARA, ALADA, and ALADAIP: a critical review
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
This study carried out a critical review of the principles
of radioprotection, including the ALARA, ALADA, and ALADAIP
principles. The Google Scholar and PubMed databases were the
search resources, and the following keywords were searched:
Linear No-Threshold (LNT); Biologic Effects of Ionizing Radiation
(BEIR VII); As Low As Reasonably Achievable (ALARA); As Low
As Diagnostically Acceptable (ALADA); As Low As Diagnostically
Acceptable, being Indication-oriented and Patient-specific (ALADAIP).
This critical review included studies with historical references,
reviews, position papers, and clinical and experimental studies.
Regarding data extraction, only original articles were selected after
the screening process. Much of the current evolution of X-ray machines
and radioprotection protocols has stemmed from legitimate concerns
about this topic. This development has grown out of the relevant
work of organizations like ICRP, UNSCEAR, and other renowned
international organizations. Low doses of radiation, such as those used
for diagnosis, also occur naturally and are present in everyday life.
Although there is no agreement on the actual risk involving low doses,
the recommendations of ALARA, ALADA, and ALADAIP prevail, in
line with the trend to uphold principles that balance the importance
of X-ray diagnostic imaging with the intention of keeping the doses
as low as possible. The benefits of X-ray exams, when justified, tend to
outweigh the low risks attributed to them.
Descrição
Palavras-chave
Citação
MENDONCA, Rafael Pereira de et al. Principles of radiological protection and application of ALARA, ALADA, and ALADAIP: a critical review. Brazilian Oral Research, São Paulo, v. 39, e014, 2025. DOI: 10.1590/1807-3107bor-2025.vol39.014. Disponível em: https://www.scielo.br/j/bor/a/cGxbyx4qKz7vvVcXP5GShjt/?format=html&lang=en. Acesso em: 6 jan. 2025.